<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="36253" whole_study_id="36253" phs="001910" v="1" p="1" createDate="2019-09-15T02:19:31-05:00" completedByGPADate="2019-09-15T02:48:58-05:00" modDate="2019-11-28T01:54:47-05:00" maxParentChildStudyModDate="2019-11-28T01:54:47-05:00" handle="Enhancer_PNETs" num_participants="47"><StudyInfo accession="phs001910.v1.p1" parentAccession="phs001910.v1.p1"><BioProject id="PRJNA575773" entrez_id="575773" type="bp_admin_access"/><BioProject id="PRJNA575774" entrez_id="575774" type="bp_data_submission"/><StudyNameEntrez>Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="epigen"/><StudyType22 name="rnaseq_whole_targ_transcriptome"/></StudyType21><StudyType21 name="supporting_documents" chosen="Yes"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="dna"/><StudyType22 name="rna"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>individual_sequencing</StudyType><StudyType>supporting_documents</StudyType><StudyType>dna</StudyType><StudyType>rna</StudyType><StudyType>whole_transcriptome</StudyType><StudyType>epigen</StudyType><StudyType>rna_seq_derived_expression</StudyType></StudyTypes></StudyInfo><Authority><ICs><IC id="4" name="NCI" is_funding_ic="true" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="BBERNSTEIN" aid="2" auth="eRA" login="BBERNSTEIN" fname="Bradley" mname="E" lname="Bernstein" email="Bernstein.Bradley@mgh.harvard.edu"><Role allow_direct_access="true">PI</Role><Organization>BROAD INSTITUTE, INC.BRIGHAM AND WOMEN'S HOSPITALMASSACHUSETTS GENERAL HOSPITAL</Organization></Person><Person nedid="0013547687" aid="1" auth="cit" login="nothwehrs" fname="Steven" mname="F" lname="Nothwehr" email="nothwehrs@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="DRIERYOTAM" aid="2" auth="eRA" login="DRIERYOTAM" fname="Yotam" mname="" lname="Drier" email="yotam.drier@mail.huji.ac.il"><Role>PI_ASSIST</Role><Organization>HEBREW UNIVERSITY OF JERUSALEM</Organization></Person><Person nedid="2002777465" aid="1" auth="cit" login="wuz8" fname="Zhuoxi" mname="" lname="Wu" email="joe.wu@nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011559580" aid="1" auth="cit" login="stefanov" fname="Stefan" mname="Alexandrov" lname="Stefanov" email="stefanov@mail.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014159529" aid="1" auth="cit" login="waltont" fname="Tamara" mname="Bene" lname="Walton" email="waltont@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>The present study has been supported by the Neuroendocrine Tumor Research Foundation (R.A.S., B.E.B., M.H.K. and D.C.C.), the SPORE program in gastrointestinal cancers (P50CA127003&#8212;National Cancer Institute, R.A.S.), the North American Neuroendocrine Tumor Society (C.M.H.) and a grant (no. PI18-01604 to P.C.) from Instituto de Salud Carlos III of the Spanish Economy and Competitiveness Ministry. See additional details at: Cejas P, Drier Y, et al. Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors. Nature Medicine 2019. doi:10.1038/s41591-019-0493-4.</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="contr_access" gsr_mode_label="Controlled-access (GSR are sensitive according to the Institutional Certification)"/><ConsentGroup uid="3659" CGType="cg_class_DS" title="Disease-Specific (Pancreatic Cancer, MDS)" name="DS-PACA-MDS" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Pancreatic Cancer.
Use of the data includes methods development research (e.g., development of software or algorithms).

</Use-Restriction></ConsentGroup><ConsentGroup uid="3660" CGType="cg_class_DS" title="Disease-Specific (Pancreatic Cancer, NPU, MDS)" name="DS-PACA-NPU-MDS" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Pancreatic Cancer.
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms).

</Use-Restriction></ConsentGroup><ConsentGroup uid="3662" CGType="cg_class_HMB" title="Health/Medical/Biomedical" name="HMB" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.

</Use-Restriction></ConsentGroup><AdditionalEmails><Email>yotam.drier@mail.huji.ac.il</Email><Email>Bernstein.Bradley@mgh.harvard.edu</Email></AdditionalEmails></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>